GRCE vs RADX
Comparison between Acasti Pharma Inc (GRCE, Company) and Radiopharm Theranostics Ltd (RADX, Company).
Both GRCE and RADX are from the Healthcare sector.
GRCE vs RADX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
GRCE
$36M
Winner
RADX
$36M
Max Drawdown
Winner
GRCE
60.00%
RADX
79.68%
Sharpe Ratio
GRCE
0.07
Winner
RADX
0.45
5Y Beta
GRCE
0.90
Winner
RADX
0.44
Industry
GRCE
Biotechnology
RADX
Biotechnology
P/E Ratio
GRCE
-5.64
RADX
N/A
Forward P/E
GRCE
2.17
RADX
N/A
Debt to Equity
GRCE
0.00%
RADX
N/A
Free Cash Flow Yield
GRCE
-28.09%
RADX
N/A
P/S Ratio
GRCE
197.75
Winner
RADX
2.22
P/B Ratio
Winner
GRCE
0.61
RADX
1.13
GRCE vs RADX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
GRCE
-1.29%
RADX
-5.88%
3M
GRCE
-38.83%
Winner
RADX
-7.49%
6M
GRCE
-28.57%
Winner
RADX
-9.05%
1Y
GRCE
-22.30%
Winner
RADX
-9.83%
Max(CAGR)
Winner
GRCE
-15.16%
RADX
-60.96%
GRCE vs RADX - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | GRCE | RADX |
|---|---|---|
| 2026 | -37.16% | -16.28% |
| 2025 | -13.50% | +12.50% |
| 2024 | +23.84% | -74.59% |
GRCE vs RADX Drawdown Comparison
The maximum drawdown for GRCE was -60.00%, occurring on Apr 7, 2025. Recovery took 323 trading sessions.
The maximum drawdown for RADX was -79.68%, occurring on Jul 7, 2025. This drawdown has not yet recovered.
The current GRCE drawdown is -55.17%. The current RADX drawdown is -77.14%.
| Rank | GRCE | RADX |
|---|---|---|
| #1 | -60.00% Dec 6, 2024 - Mar 25, 2026 | -79.68% Dec 6, 2024 - Jul 7, 2025 |
| #2 | -59.06% Apr 2, 2026 - Apr 28, 2026 | N/A |
| #3 | -18.06% Oct 23, 2024 - Dec 4, 2024 | N/A |
| #4 | -8.60% Mar 26, 2026 - Apr 1, 2026 | N/A |
| #5 | -5.57% Oct 10, 2024 - Oct 23, 2024 | N/A |
Correlation
Correlation between GRCE and RADX is 0.17 which considered as a very weak or no correlation - the stocks move independently of each other.
0.17
-101
Select Stocks to Compare
Popular: GRCE vs SPYRADX vs SPY
More Comparisons
Compare with similar stocks